Mass spectrometry-based proteomics: technological advances and their application to plasma and single cell type resolved tissue proteo
September 13 @ 16:00 – 17:00 CEST
Mass spectrometry-based proteomics: technological advances and their application to plasma and single cell type resolved tissue proteomics
Welcome to a lecture by Professor Matthias Mann, Max Planck Institute, Germany.
- 16.00-17.00 Tuesday September 13
- Air & Fire (Gamma 2) or
- via zoom https://kth-se.zoom.us/s/69393882589
Matthias Mann obtained his PhD in chemical engineering at Yale, contributing to the Nobel Prize for his supervisor John Fenn for electrospray ionization. He is a director at the Max Planck Institute of Biochemistry, Munich and also director of the Department of Proteomics, Novo Nordisk Foundation Center for Protein Research at the University of Copenhagen. He has obtained numerous prizes and is one of the most cited scientists with an h-factor of 250 and 300,000 total citations (Google Scholar). He has pioneered advances in sample preparation, chromatography, mass spectrometry and computer algorithms, making mass spectrometry applicable to molecular biology. Apart from proteomics technology development, the team works on biological questions in systems biology. Today, the main focus is on clinically relevant topics, especially the analysis of the blood plasma proteome and cancer tissues at the single-cell level.
This keynote lecture is part of the FEBS Advanced Course – Exploring the Human Proteome